12 2 STA T .483 3 PUBLIC LA W 11 0– 42 5—O CT. 15 , 2008 (C)RULEOFC O NSTR UCT I ON .—Nothing in thi s s ub- s ec tion may be const r ue d to create a p recedent that any speci f ic course of conduct constitutes the ‘ ‘practice of te l e- medicine ’ ’ (as that term is defined in section 102 ( 54 )of the Controlled S ubstances A ct , as amended by this Act) after the end of the period specified in subparagraph (A). ( k ) G UI D ELINES A ND RE G ULATIONS.— (1) I N GENERAL.— T he Attorney General may promulgate and enforce any rules, regulations, and procedures w hich may be necessary and appropriate for the efficient e x ecution of func- tions under this Act or the amendments made by this Act, and, with the concurrence of the Secretary of H ealth and Human Ser v ices where this Act or the amendments made by this Act so provide, promulgate any interim rules necessary for the implementation of this Act or the amendments made by this Act, prior to its effective date. (2) SENTENCING GUIDELINES.—The U nited States Sen- tencing Commission, in determining whether to amend, or establish new, guidelines or policy statements, to conform the F ederal sentencing guidelines and policy statements to this Act and the amendments made by this Act, should not construe any change in the maximum penalty for a violation involving a controlled substance in a particular schedule as being the sole reason to amend, or establish a new, guideline or policy statement. (l) ANNUAL RE P ORT.—Not later than 1 8 0 days after the date of enactment of this Act, and annually for 2 years after the initial report, the D rug E nforcement Administration, in consultation with the Department of State, shall submit to Congress a report describing— (1) the foreign supply chains and sources of controlled substances offered for sale without a valid prescription on the Internet
(2) the efforts and strategy of the Drug Enforcement Administration to decrease the foreign supply chain and sources of controlled substances offered for sale without a valid prescrip- tion on the Internet; and ( 3 ) the efforts of the Drug Enforcement Administration to work with domestic and multinational pharmaceutical companies and others to build international cooperation and a commitment to fight on a global scale the problem of distribu- tion of controlled substances over the Internet without a valid prescription. 28USC9 9 4note. 2 1 USC 8 0 2 note.
�
